Company filings, made visual.

Find a company. Follow its revenue through costs and profit.

Market

Find a company or ticker

Coverage includes separate ticker and security records; counts are not unique companies.

Glaukos Corporation

GKOS

Filing: SEC 10-Q
Period: Three months ended March 31, 2026
Basis: Editorial filing; Read original SEC 10-Q ↗

Sankey diagram of Glaukos Corporation. A complete text table follows the diagram.

Glaukos Converts Ophthalmic Devices Into Product Sales

The filing supports a consolidated ophthalmic-device platform.

Swipe to explore

Source & review

Read original SEC 10-Q ↗

SEC accession: 0001193125-26-193004
Filed: Date not recorded
Reviewed: Date not recorded
Status: Individual filing review complete

How to read these figures

Labels and displayed flow values are reported filing values or exact disclosed subtotals.

Labels and narrative explain the filing. A category marked “arithmetic bridge” or “residual” is calculated from reported totals, rather than a separately reported line.

The filing reports $150.571M net sales; no unsupported split is added.

View accessible tables

Financial categories · Three months ended March 31, 2026 · Millions of USD
Category	Stage	Value	Notes
Glaukos Corporation revenue	1	$151M	$150.6M reported quarterly revenue
Ophthalmic devices and therapies	2	$151M	Reported net sales

Financial flows · Millions of USD
From	To	Value
Glaukos Corporation revenue	Ophthalmic devices and therapies	$151M